Cargando…

Global variation in sequencing impedes SARS-CoV-2 surveillance

Detalles Bibliográficos
Autores principales:	Crawford, Dana C., Williams, Scott M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Viewpoints
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8282079/ https://www.ncbi.nlm.nih.gov/pubmed/34264957 http://dx.doi.org/10.1371/journal.pgen.1009620

Ejemplares similares

SARS-CoV-2 Vaccination in India: Considerations of Hesitancy and Bioethics in Global Health
por: Sarkar, Mohammad Abdullah, et al.
Publicado: (2021)

SARS-CoV-2: The Second Wave in Europe
por: Fokas, Athanassios S, et al.
Publicado: (2021)

SARS-CoV-2 vaccine development, access, and equity
por: Kim, Jerome H.
Publicado: (2020)

Human-Animal Interaction and the Emergence of SARS-CoV-2
por: Hassani, Asma, et al.
Publicado: (2020)

Schrödinger’s Worker: Are They Positive or Negative for SARS-CoV-2?
por: Meloni, Federico, et al.
Publicado: (2020)

Tumor markers as an entry for SARS‐CoV‐2 infection?
por: Xia, Pu, et al.
Publicado: (2020)

Wearables in the SARS-CoV-2 Pandemic: What Are They Good for?
por: Bent, Brinnae, et al.
Publicado: (2020)

Epidemiological profiles of SARS-CoV and SARS-Cov-2 in Singapore and its promising containment strategies
por: Chaturvedi, Rini, et al.
Publicado: (2021)

Can Robots Improve Testing Capacity for SARS-CoV-2?
por: Cresswell, Kathrin, et al.
Publicado: (2020)

Reducing Aerosol Transmission of SARS-CoV-2 in Craniomaxillofacial Osteosynthesis
por: Arakeri, Gururaj, et al.
Publicado: (2020)

In defence of extrapolation but not improvisation in SARS-CoV-2 lung disease
por: Epelbaum, Oleg, et al.
Publicado: (2020)

Targeting neuropilins as a viable SARS‐CoV‐2 treatment
por: Sarabipour, Sarvenaz, et al.
Publicado: (2021)

Recommendations for return to sport during the SARS-CoV-2 pandemic
por: Löllgen, Herbert, et al.
Publicado: (2020)

Understanding SARS‐CoV‐2 endocytosis for COVID‐19 drug repurposing
por: Glebov, Oleg O.
Publicado: (2020)

Role of Eyes and Eyes Protection Amidst SARS-CoV-2 Infection
por: Thapa, Bibechan
Publicado: (2021)

Elimination versus mitigation of SARS-CoV-2 in the presence of effective vaccines
por: Oliu-Barton, Miquel, et al.
Publicado: (2022)

A focus on the spread of the delta variant of SARS-CoV-2 in India
por: Novelli, Giuseppe, et al.
Publicado: (2021)

Could the Biogeographic Background Affect the Emergence of SARS-CoV-2 Variants?
por: Akaishi, Tetsuya
Publicado: (2022)

Defensins: Therapeutic molecules with potential to treat SARS-CoV-2 infection
por: Banu, Sarena, et al.
Publicado: (2022)

SARS-CoV-2 in Malawi: Are we sacrificing the Youth in sub-Saharan Africa?
por: Nandi, Biplap, et al.
Publicado: (2020)

Contact lens use at the time of SARS-CoV-2 pandemic for healthcare workers
por: Bhargava, Raghav
Publicado: (2020)

Hospital preparedness for mass critical care during SARS-CoV-2 pandemic
por: Wurmb, Thomas, et al.
Publicado: (2020)

EULAR December 2020 viewpoints on SARS-CoV-2 vaccination in patients with RMDs
por: Bijlsma, Johannes WJ
Publicado: (2021)

SARS-CoV-2 and COVID-19: revisiting the most important research questions
por: Yuen, Kit-San, et al.
Publicado: (2021)

Longitudinal sampling sheds light on SARS-CoV-2 fecal shedding dynamics
por: Coryell, Michael P., et al.
Publicado: (2022)

Considering innate immune responses in SARS-CoV-2 infection and COVID-19
por: Diamond, Michael S., et al.
Publicado: (2022)

COVID-19 and SARS-CoV-2 Vaccines: A Cameo Role for Headache
por: Martelletti, Paolo
Publicado: (2023)

SARS-CoV-2 and displaced persons in Afghanistan: A blind spot in epidemic preparedness
por: Flower, Benjamin CR, et al.
Publicado: (2020)

The SARS-CoV-2 crisis and its impact on neglected tropical diseases: Threat or opportunity?
por: Chaumont, Claire, et al.
Publicado: (2020)

Unpacking the Implications of SARS-CoV-2 Breakthrough Infections on COVID-19 Vaccination Programs
por: Dzinamarira, Tafadzwa, et al.
Publicado: (2022)

Transmission of SARS-CoV-2 on cold-chain food overpacks: A new challenge
por: Chi, Yuhua, et al.
Publicado: (2021)

SARS-CoV2: should inhibitors of the renin–angiotensin system be withdrawn in patients with COVID-19?
por: Kuster, Gabriela M, et al.
Publicado: (2020)

Harnessing autophagy to fight SARS‐CoV‐2: An update in view of recent drug development efforts
por: Rein, Theo
Publicado: (2021)

The Role of Unobtrusive Home-Based Continuous Sensing in the Management of Postacute Sequelae of SARS CoV-2
por: Corman, Benjamin Harris Peterson, et al.
Publicado: (2022)

Marketing SARS-CoV-2 Vaccines: an Opportunity to Test a Nobel Prize–Winning Theory
por: Verma, Amol A., et al.
Publicado: (2021)

The myth that Nigerians are immune to SARS-CoV-2 and that COVID-19 is a hoax are putting lives at risk
por: Aiyewumi, Oluwadamilola, et al.
Publicado: (2020)

Can Disinfection Robots Reduce the Risk of Transmission of SARS-CoV-2 in Health Care and Educational Settings?
por: Cresswell, Kathrin, et al.
Publicado: (2020)

Diagnostic tool or screening programme? Asymptomatic testing for SARS-CoV-2 needs clear goals and protocols
por: Skittrall, Jordan P, et al.
Publicado: (2020)

SARS-CoV-2 spread in different biosocial strata in Russia in 2020: Groups of risk and victimised groups
por: Sharov, Konstantin S
Publicado: (2021)

Nasal vaccine or monoclonal therapy: Which is winning weapon against SARS-CoV-2 variants in 2022?
por: Lo Muzio, Lorenzo, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_chd1fd47aqimplb4s8d0l3rkv9